• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Read More - WuXi NextCODE
Read More - WuXi NextCODE

... safety, pharmacokinetics and preliminary antitumor activities, with plans to expand quickly if all goes well. “This is a big accomplishment for a company like us – developing an antibody drug is much more complex, both preclinically and clinically, than a small molecule,” said Yang. “We are happy to ...
pps
pps

... existing words and words that imply a direct connection or target a specific consumer group cannot be protected. Example: „Schülerschokolade“ is not possible in Germany Thus a lot of inspiration is required to find a pleasant sounding name. Frequently syllables and foreign words (latin, greek, spani ...
AAPM Report No 121
AAPM Report No 121

... responsibility and ultimately the liability for off-label use often rest with the prescribing physician, the medical physicist and others may also be responsible for the safe and proper use of the medical products. When these products are used for purposes other than which they were approved, it is ...
New Project Application - Clinical Trials
New Project Application - Clinical Trials

controlled drugs
controlled drugs

Antibodies to Biotherapeutics
Antibodies to Biotherapeutics

PDF - Dechert LLP
PDF - Dechert LLP

... holding that Biovail’s antitrust claims against Andrx should not have been dismissed by the district court; In re Cardizem CD Antitrust Litig., 105 F. Supp. 2d 618 (E.D. Mich. 2000), holding, inter alia, that the plaintiffs stated a claim that defendants were engaged in a sham transaction rendering ...
b.pharm v semister - Andhra University
b.pharm v semister - Andhra University

8 Steroids
8 Steroids

... LYBREL approved June 2006 by FDA 90 mg levonorgestrel, 20 mg ethynyl estradiol Continuous use – no periods at all, though ~ 40% find some spotting during first year WYETH REPORTS THAT The study showed that 99 percent of 187 participants experienced either a return to menses or became pregnant withi ...
IND_Minutesdraft_27.02.1
IND_Minutesdraft_27.02.1

... whereas the proposed dose in the study is 250mg BD. Pharmacokinetic data for 250mg BD in other countries is required to be submitted. 4. Firm informed that there are 14-30% population of NAFLD. The experts raised concern over this figure and advised the firm to correct it. 5. Investigator’s CVs, dul ...
Pfizer, Inc - Pearson Higher Education
Pfizer, Inc - Pearson Higher Education

... Tetra was the world’s leading provider of products for the ornamental fish food market, including TetraMin fish foods and other fish care products. Tetra was the only brand name synonymous with ornamental fish-keeping. Founded by Dr. Ulrich Bensch in Mele, Germany, Tetra pioneered the development of ...
Getting Noticed: The Importance of
Getting Noticed: The Importance of

... Case Study – Purple Pill • Purple Pill - a prescription drug Prilosec manufactured by AstraZeneca for relief from heartburn caused by acid reflux disease. • An huge marketing campaign was carried out in 1997, where advertisements for the “Purple Pill” appeared everywhere—on TV, the Internet, and in ...
AusPAR: Tafluprost/Timolol - Therapeutic Goods Administration
AusPAR: Tafluprost/Timolol - Therapeutic Goods Administration

Strategic Analysis for Sanofi-Aventis Group  Group Project
Strategic Analysis for Sanofi-Aventis Group Group Project

... insurers, health maintenance organizations and managed care organizations increasingly challenge pharmaceutical product pricing. This trend towards managed healthcare in the US has led to various legislative proposals and enactments to reform healthcare and government insurance programs. In 1984, th ...
Controlled Release Softgel Drug Delivery
Controlled Release Softgel Drug Delivery

SUSTAINED DRUG DELIVERY TO THE POSTERIOR SEGMENTS
SUSTAINED DRUG DELIVERY TO THE POSTERIOR SEGMENTS

Leading in
Leading in

... of supply for the design, development, for MDIs to the exacting standards required by international regulatory manufacture and assembly of valves and cans authorities. 3M Drug Delivery Systems is the only valve manufacturer that for MDIs. 3M Drug Delivery Systems is the only integrates in-house meta ...
Shan Chikhale, Professor of Pharmaceutical Sciences, School of
Shan Chikhale, Professor of Pharmaceutical Sciences, School of

Introduction to Medicinal Chemistry
Introduction to Medicinal Chemistry

... INTRODUCTION TO MEDICINAL CHEMISTRY ...
Handbook of Extemporaneous Preparation
Handbook of Extemporaneous Preparation

... in its country of origin should be considered. However, it must be noted that the presence of a non-UK marketing authorisation confers no legal status on the medicine in the UK and that importation can only take place through a company holding a Wholesale Dealer (Import) Licence. The preparation sel ...
November 3, 2013 Boca Raton, Florida Anesthetics in Cosmetic M
November 3, 2013 Boca Raton, Florida Anesthetics in Cosmetic M

... • December 2006: FDA warning letter • The Food and Drug Administration (FDA) warned 5 firms to stop compounding and distributing standardized versions of topical anesthetic creams, which are marketed for general distribution rather than responding to the unique medical needs of individual patients • ...
Yellow iron oxide (E172) 0.1875 mg
Yellow iron oxide (E172) 0.1875 mg

... inhibition of COX-2 versus COX-1. Clinical relevance of these data has not be shown. Carprofen has also been shown to inhibit the release of several prostaglandins in two inflammatory cell systems: rat polymorphonuclear leukocytes (PMN) and human rheumatoid synovial cells, indicating inhibition of a ...
Executive order on monitoring of adverse reactions from medicinal
Executive order on monitoring of adverse reactions from medicinal

... or this combination of active substances. The European Medicines Agency publishes decisions about the harmonised frequency and dates for the submission of periodic safety update reports. All amendments become effective six months after the publication. Following the European Medicines Agency’s publi ...
comp11_unit3_2_lecture
comp11_unit3_2_lecture

Identifying Potential Adverse Drug Events in Tweets Using
Identifying Potential Adverse Drug Events in Tweets Using

... more loosely define any overlapping period of drug treatment and adverse medical effects. Importantly, ADEs do not imply causation between the drug use and co-occurring negative event (Eriksson et al., 2013). Timely, accurate identification of these medical complications therefore facilitates improv ...
< 1 ... 77 78 79 80 81 82 83 84 85 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report